---
$id: https://graph.org.ai/products/commodity/51111741
$type: Product
source: UNSPSC
code: "51111741"
title: "Demecolcine"
class: "51111700"
classTitle: "Antineoplastic antibiotics"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Demecolcine

**UNSPSC Code**: 51111741
**Class**: [Antineoplastic antibiotics](Antineoplastic antibiotics.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a colchicine-site binding agent with the molecular formula C21H25NO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z01IVE25KI, chemically known as 6,7-dihydro-1,2,3,10-tetramethoxy-7-(methylamino)-benzo(alpha)heptalen-9(5h)-one but generally known as demecolcine, which bears US NIH Compound Identifier 2832. European Medicines Agency schedules Demecolcine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06964MIG. The term DEMECOLCINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). World Health Organization schedules demecolcine in its Anatomical Therapeutic Chemical (ATC) Classification. DEMECOLCINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule demecolcine under HS 29399900 and SITC 54149. As of Q4 2014, DEMECOLCINE remains the US FDA Preferred Term for this commodity. Demecolcine bears US NLM identifiers UMLS ID C0011259 and NCI Concept Code C419. SMILES: O(C1C2C(CCC(NC)C3C2CCC(OC)C(=O)C3)CC(OC)C1OC)C.

